Vetsulin is a well-established porcine insulin zinc suspension widely used in canine diabetes management and valued for its predictable intermediate-acting profile and extensive clinical history. As a market leader it combines broad availability and clinician familiarity—advantages over newer veterinary-specific insulins like Prozinc—and while it can be pricier than human NPH alternatives, many vets prefer it for its canine-focused labeling and dosing guidance.
Canine-specific formula
Vial dosing option
Canine-specific formula
Vial dosing option
Review Summary
"Vetsulin is widely regarded as effective and affordable for many diabetic dogs, with many users achieving good control after proper dosing and mixing; critiques focus on the need for careful resuspension and occasional inconsistency between vials. Long‑term users appreciate its veterinary formulation and cost profile."
Puppy-wag worthy
Porcine insulin zinc suspension with a long history of use and evidence in canine diabetes care.
Puppy-wag worthy
Porcine insulin zinc suspension with a long history of use and evidence in canine diabetes care.
Increased Safety & Security
Skill Development & Mastery
Vetsulin is a well-established porcine insulin zinc suspension widely used in canine diabetes management and valued for its predictable intermediate-acting profile and extensive clinical history. As a market leader it combines broad availability and clinician familiarity—advantages over newer veterinary-specific insulins like Prozinc—and while it can be pricier than human NPH alternatives, many vets prefer it for its canine-focused labeling and dosing guidance.
Canine-specific formula
Vial dosing option
Puppy-wag worthy
Porcine insulin zinc suspension with a long history of use and evidence in canine diabetes care.
Intermediate-acting profile typically administered twice daily with meals for stable glycemic control.
Canine-specific formula
Vial dosing option
Puppy-wag worthy
Porcine insulin zinc suspension with a long history of use and evidence in canine diabetes care.
Intermediate-acting profile typically administered twice daily with meals for stable glycemic control.
$90-170 USD
Vetsulin (Caninsulin)
Vetsulin (marketed as Caninsulin in some regions) is a veterinary porcine insulin zinc suspension widely regarded as the market-leading insulin therapy for canine diabetes because of its established clinical track record and predictable glycemic control. Although it is an injectable product rather than an oral regulator, its technical advantage is robust efficacy where oral agents often fail, making it the go-to choice for dogs requiring definitive insulin replacement. Financially, Vetsulin's pricing reflects its regulatory approvals and manufacturer support, which can be higher than compounded oral options but is justified by superior clinical consistency and product reliability.
Fast glucose control - tail-approved
Dog-specific insulin formula
Fast glucose control - tail-approved
Dog-specific insulin formula
Review Summary
"Users generally report reliable glycemic control with Vetsulin/Caninsulin when dosed and handled properly; some cite variability between batches and occasional dosing challenges but overall steady improvement in diabetic dogs."
Vet-prescribed reliability
Porcine lente insulin (Vetsulin/Caninsulin) formulated specifically for dogs and cats.
Vet-prescribed reliability
Porcine lente insulin (Vetsulin/Caninsulin) formulated specifically for dogs and cats.
Increased Safety & Security
Skill Development & Mastery
Vetsulin (marketed as Caninsulin in some regions) is a veterinary porcine insulin zinc suspension widely regarded as the market-leading insulin therapy for canine diabetes because of its established clinical track record and predictable glycemic control. Although it is an injectable product rather than an oral regulator, its technical advantage is robust efficacy where oral agents often fail, making it the go-to choice for dogs requiring definitive insulin replacement. Financially, Vetsulin's pricing reflects its regulatory approvals and manufacturer support, which can be higher than compounded oral options but is justified by superior clinical consistency and product reliability.
Fast glucose control - tail-approved
Dog-specific insulin formula
Vet-prescribed reliability
Porcine lente insulin (Vetsulin/Caninsulin) formulated specifically for dogs and cats.
Typically administered by subcutaneous injection, often twice daily with dose titration based on glucose curves.
Fast glucose control - tail-approved
Dog-specific insulin formula
Vet-prescribed reliability
Porcine lente insulin (Vetsulin/Caninsulin) formulated specifically for dogs and cats.
Typically administered by subcutaneous injection, often twice daily with dose titration based on glucose curves.
$90-150 USD
Soloxine
Soloxine is a long-established veterinary levothyroxine product known for consistent potency and broad availability, making it a common first-line prescription for canine hypothyroidism. Compared with newer entrants such as Leventa or niche products like Thyrosyn, Soloxine balances reliability and predictable clinical response with mid-market pricing, which can be financially advantageous for clinics seeking a trusted standard without the premium of specialty formulations.
Consistent potency
Easy-to-split
Consistent potency
Easy-to-split
Review Summary
"Soloxine is commonly described as effective and affordable for long-term thyroid replacement, with many owners seeing clear improvements after dose optimization; some report availability issues or the need for close monitoring to avoid over- or under-dosing. Most reviews praise its value and clinical reliability."
Veterinary staple
Established levothyroxine (T4) product with a long clinical track record in canine hypothyroidism.
Veterinary staple
Established levothyroxine (T4) product with a long clinical track record in canine hypothyroidism.
Increased Safety & Security
Time-Saving Convenience
Soloxine is a long-established veterinary levothyroxine product known for consistent potency and broad availability, making it a common first-line prescription for canine hypothyroidism. Compared with newer entrants such as Leventa or niche products like Thyrosyn, Soloxine balances reliability and predictable clinical response with mid-market pricing, which can be financially advantageous for clinics seeking a trusted standard without the premium of specialty formulations.
Consistent potency
Easy-to-split
Veterinary staple
Established levothyroxine (T4) product with a long clinical track record in canine hypothyroidism.
Offered in several strengths to permit precise dosing adjustments.
Consistent potency
Easy-to-split
Veterinary staple
Established levothyroxine (T4) product with a long clinical track record in canine hypothyroidism.
Offered in several strengths to permit precise dosing adjustments.
$40-150 USD
Percorten-V Injectable
Percorten‑V (desoxycorticosterone pivalate, DOCP) Injectable is the market‑leading long‑acting parenteral mineralocorticoid for dogs with primary hypoadrenocorticism, delivering predictable monthly electrolyte control. Its technical advantage over oral Florinef is steadier mineralocorticoid replacement with fewer compliance issues and often better long‑term cost‑effectiveness despite higher upfront injection visit charges; because it lacks glucocorticoid activity it is routinely used alongside a separate glucocorticoid such as prednisolone.
Long-acting injection
Fewer daily pills
Long-acting injection
Fewer daily pills
Review Summary
"Percorten-V is widely praised for consistent, long-lasting mineralocorticoid replacement and predictable monthly control; main complaints are expense and the necessity of veterinary-administered injections."
Bounce-back energy
Monthly injectable desoxycorticosterone pivalate for reliable mineralocorticoid replacement.
Bounce-back energy
Monthly injectable desoxycorticosterone pivalate for reliable mineralocorticoid replacement.
Increased Safety & Security
Time-Saving Convenience
Percorten‑V (desoxycorticosterone pivalate, DOCP) Injectable is the market‑leading long‑acting parenteral mineralocorticoid for dogs with primary hypoadrenocorticism, delivering predictable monthly electrolyte control. Its technical advantage over oral Florinef is steadier mineralocorticoid replacement with fewer compliance issues and often better long‑term cost‑effectiveness despite higher upfront injection visit charges; because it lacks glucocorticoid activity it is routinely used alongside a separate glucocorticoid such as prednisolone.
Long-acting injection
Fewer daily pills
Bounce-back energy
Monthly injectable desoxycorticosterone pivalate for reliable mineralocorticoid replacement.
Provides consistent electrolyte control with less frequent dosing than oral options.
Long-acting injection
Fewer daily pills
Bounce-back energy
Monthly injectable desoxycorticosterone pivalate for reliable mineralocorticoid replacement.
Provides consistent electrolyte control with less frequent dosing than oral options.
$120-250 USD
Percorten-V DOCP Injection
Percorten-V (DOCP) injection is the standard long-acting mineralocorticoid replacement for canine hypoadrenocorticism, delivering predictable monthly electrolyte control and removing the need for daily oral mineralocorticoid dosing. Its technical advantage is a dependable, clinic-administered depot effect that reduces owner pill burden and stabilizes sodium/potassium ratios, which—despite requiring periodic veterinary visits—often lowers long-term monitoring variability and overall management costs compared with daily oral alternatives.
Stabilizes electrolytes
Long-lasting injection
Stabilizes electrolytes
Long-lasting injection
Review Summary
"Percorten-V (DOCP) injections are widely praised for reliably managing Addison's disease with monthly dosing and predictable clinical improvement; owners appreciate the effectiveness though they mention cost and the need for periodic electrolyte monitoring."
Monthly lifesaver
DOCP (Percorten-V) is a long-acting injectable mineralocorticoid used to replace aldosterone in primary hypoadrenocorticism.
Monthly lifesaver
DOCP (Percorten-V) is a long-acting injectable mineralocorticoid used to replace aldosterone in primary hypoadrenocorticism.
Increased Safety & Security
Time-Saving Convenience
Percorten-V (DOCP) injection is the standard long-acting mineralocorticoid replacement for canine hypoadrenocorticism, delivering predictable monthly electrolyte control and removing the need for daily oral mineralocorticoid dosing. Its technical advantage is a dependable, clinic-administered depot effect that reduces owner pill burden and stabilizes sodium/potassium ratios, which—despite requiring periodic veterinary visits—often lowers long-term monitoring variability and overall management costs compared with daily oral alternatives.
Stabilizes electrolytes
Long-lasting injection
Monthly lifesaver
DOCP (Percorten-V) is a long-acting injectable mineralocorticoid used to replace aldosterone in primary hypoadrenocorticism.
Administered by deep IM or SC injection approximately every 25–30 days with concurrent glucocorticoid management as indicated.
Stabilizes electrolytes
Long-lasting injection
Monthly lifesaver
DOCP (Percorten-V) is a long-acting injectable mineralocorticoid used to replace aldosterone in primary hypoadrenocorticism.
Administered by deep IM or SC injection approximately every 25–30 days with concurrent glucocorticoid management as indicated.
$100-350 USD